Video

Portable laser technology receives high marks

Author(s):

Harit Bhatt, MD, a Chicagoland-area retinal surgeon, shared his experience with the LEAF and LION portable lasers during a conversation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago.

Video transcript

Note: This transcript has been lightly edited for clarity.

Harit Bhatt, MD: Hi, my name is Harit Bhatt. I'm a retinal surgeon that works in the southwest suburbs of the Chicagoland area. I work at University Retina and Macula Associates, I've had the pleasure of using the LEAF and LION for the last several months, and it's completely revolutionized how I treat patients with laser.

No. 1, the value proposition of mobility and portability has been elegantly executed. Not only in what I do in my clinic day to day where I don't have to move patients, I can move the laser, but also the portability of it for me to take it to other clinics should I need to use it when I travel there.

The accuracy, the optics, the reliability, the user interface have all been a big leap forward in laser technology and at least in all of the other companies and lasers I've been exposed to. So it's been a real pleasure with incorporating the Noralase into my practice and also working with the Noralase team they've been very supportive. I've actually turned other people on to this.

I don't think you truly know how easy it is to use and how valuable it can be until you actually get your hands on it and use it in your office. And I think that there are demo programs been very helpful for that.

I think for patients it is great. I think it means less movement in the office, shorter wait times in the office, and it allows them to be seen in a more efficient way for their treatments. And that's just the operation side of it. In addition to that, the quality of the laser, the comfortability of the treatment and the accuracy of it is probably produces more comfortable, you know, treatment, therapy and also better outcomes.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.